| Listing Country | USA |
| Status | Shelf |
| Currency | USD |
| date of listing | NA |
| CIK | 1103601 |
| OFFER_TYPE | Secondary |
| NAME | WGL Holdings, Inc. |
| LOCATION | Washington, DC |
| SYMBOL | WGL |
| EXCHANGE | NYSE |
| FILING_DATE | 2015-11-24 |
| PRICE_LOW | - |
| PRICE_HIGH | - |
| AMOUNT | $150.0 mil. |
| UWRITERS | Wells Fargo Securities, BB&T Capital Markets, RBC Capital Markets |
| IPO Type | NA |
| Offering | |
| Description of the Offering | |
| MAX shares | |
| Min Shares | |
| Over allotment option | |
| Shares Outstanding after the offering | |
| Shares offered | - |
| Primary shares | |
| secondary shares | |
| Price per share | |
| underwriter commission | |
| Gross proceeds | - |
| gross spread | - |
| Net proceeds | - |
| Source | |
Thursday, 10 December 2015
WGL Holdings, Inc. shelf offering
Calithera Biosciences, Inc. shelf offering
| Listing Country | USA |
| Status | Shelf |
| Currency | USD |
| date of listing | NA |
| CIK | 1496671 |
| OFFER_TYPE | Secondary |
| NAME | Calithera Biosciences, Inc. |
| LOCATION | South San Francisco, CA |
| SYMBOL | CALA |
| EXCHANGE | Nasdaq NM |
| FILING_DATE | 2015-11-24 |
| PRICE_LOW | - |
| PRICE_HIGH | - |
| AMOUNT | $50.0 mil. |
| UWRITERS | Cowen and Company |
| IPO Type | NA |
| Offering | |
| Description of the Offering | |
| MAX shares | |
| Min Shares | |
| Over allotment option | |
| Shares Outstanding after the offering | |
| Shares offered | - |
| Primary shares | |
| secondary shares | |
| Price per share | |
| underwriter commission | |
| Gross proceeds | - |
| gross spread | - |
| Net proceeds | - |
| Source |
ZAGG Inc. shelf offering
| Listing Country | USA |
| Status | Shelf |
| Currency | USD |
| date of listing | NA |
| CIK | 1296205 |
| OFFER_TYPE | Secondary |
| NAME | ZAGG Inc. |
| LOCATION | Salt Lake City, UT |
| SYMBOL | ZAGG |
| EXCHANGE | Nasdaq NM |
| FILING_DATE | 2015-11-25 |
| PRICE_LOW | - |
| PRICE_HIGH | - |
| AMOUNT | $100.0 mil. |
| UWRITERS | Shelf Registration (mixed) |
| IPO Type | NA |
| Offering | 274449 Common Stock |
| Description of the Offering | |
| MAX shares | |
| Min Shares | |
| Over allotment option | |
| Shares Outstanding after the offering | |
| Shares offered | ######## |
| Primary shares | ######## |
| secondary shares | ######## |
| Price per share | |
| underwriter commission | |
| Gross proceeds | - |
| gross spread | - |
| Net proceeds | - |
| Source |
Universal Health Realty Income Trust shelf offering
| Listing Country | USA |
| Status | Shelf |
| Currency | USD |
| date of listing | NA |
| CIK | 798783 |
| OFFER_TYPE | Secondary |
| NAME | Universal Health Realty Income Trust |
| LOCATION | King of Prussia, PA |
| SYMBOL | UHT |
| EXCHANGE | NYSE |
| FILING_DATE | 2015-11-30 |
| PRICE_LOW | - |
| PRICE_HIGH | - |
| AMOUNT | $100.0 mil. |
| UWRITERS | Shelf Registration (mixed) |
| IPO Type | NA |
| Offering | |
| Description of the Offering | |
| MAX shares | |
| Min Shares | |
| Over allotment option | |
| Shares Outstanding after the offering | |
| Shares offered | - |
| Primary shares | |
| secondary shares | |
| Price per share | |
| underwriter commission | |
| Gross proceeds | - |
| gross spread | - |
| Net proceeds | - |
| Source |
Amsurg Corp. secondary offering
| Listing Country | USA |
| Status | Listed |
| Currency | USD |
| date of listing | NA |
| CIK | 895930 |
| OFFER_TYPE | Secondary |
| NAME | Amsurg Corp. |
| LOCATION | Nashville, TN |
| SYMBOL | AMSG |
| EXCHANGE | Nasdaq NM |
| FILING_DATE | 2015-11-30 |
| PRICE_LOW | - |
| PRICE_HIGH | - |
| AMOUNT | N/A |
| UWRITERS | SunTrust Robinson Humphrey, J.P. Morgan, BMO Capital Markets, Jefferies & Company, Guggenheim Securities |
| IPO Type | NA |
| Offering | 5500000 Common Stock |
| Description of the Offering | |
| MAX shares | |
| Min Shares | |
| Over allotment option | ######## |
| Shares Outstanding after the offering | ######## |
| Shares offered | ######## |
| Primary shares | ######## |
| secondary shares | |
| Price per share | 80.00 |
| underwriter commission | 3.20 |
| Gross proceeds | ######## |
| gross spread | ######## |
| Net proceeds | ######## |
| Source |
T2 Biosystems, Inc. secondary offering
| Listing Country | USA |
| Status | Listed |
| Currency | USD |
| date of listing | NA |
| CIK | 1492674 |
| OFFER_TYPE | Secondary |
| NAME | T2 Biosystems, Inc. |
| LOCATION | Lexington, MA |
| SYMBOL | TTOO |
| EXCHANGE | Nasdaq NM |
| FILING_DATE | 2015-12-01 |
| PRICE_LOW | - |
| PRICE_HIGH | - |
| AMOUNT | $100.0 mil. |
| UWRITERS | Goldman Sachs & Co., Leerink Swann, Canaccord Genuity , Cantor Fitzgerald & Co. |
| IPO Type | NA |
| Offering | 3500000 Ordinary Shares |
| Description of the Offering | |
| MAX shares | |
| Min Shares | |
| Over allotment option | ######## |
| Shares Outstanding after the offering | ######## |
| Shares offered | ######## |
| Primary shares | ######## |
| secondary shares | |
| Price per share | 9.75 |
| underwriter commission | 0.61 |
| Gross proceeds | ######## |
| gross spread | ######## |
| Net proceeds | ######## |
| Source |
Titan Pharmaceuticals Inc. Shelf offering
| Listing Country | USA |
| Status | Shelf |
| Currency | USD |
| date of listing | NA |
| CIK | 910267 |
| OFFER_TYPE | Secondary |
| NAME | Titan Pharmaceuticals Inc. |
| LOCATION | San Francisco, CA |
| SYMBOL | TTNP |
| EXCHANGE | Nasdaq NM |
| FILING_DATE | 2015-11-30 |
| PRICE_LOW | - |
| PRICE_HIGH | - |
| AMOUNT | $50.0 mil. |
| UWRITERS | Shelf Registration (mixed) |
| IPO Type | NA |
| Offering | |
| Description of the Offering | |
| MAX shares | |
| Min Shares | |
| Over allotment option | |
| Shares Outstanding after the offering | |
| Shares offered | - |
| Primary shares | |
| secondary shares | |
| Price per share | |
| underwriter commission | |
| Gross proceeds | - |
| gross spread | - |
| Net proceeds | - |
| Source |
Subscribe to:
Posts (Atom)